Serviços 
O conteúdo desse portal pode ser acessível em Libras usando o VLibras
Início do conteúdo

18/11/2019

Fiocruz, UdelaR and Pasteur Institute of Montevideo sign partnership


Lucas Rocha (IOC/Fiocruz)

Oswaldo Cruz Foundation (Fiocruz), the University of the Republic of Uruguay (UdelaR) and Pasteur Institute of Montevideo signed a memorandum of understanding for future partnerships between the institutions. The meeting was held at UdelaR’s headquarters in Montevideo, on October 28.

The meeting was attended by the director of the Oswaldo Cruz Institute (IOC/Fiocruz), José Paulo Gagliardi Leite; Fiocruz’s Vice-Presidents Rodrigo Correa de Oliveira (Biological Research and Collections) and Marco Krieger (Production and Innovation in Health), representing Fiocruz’s President, Nísia Trindade Lima; the director of the Carlos Chagas Institute (Fiocruz Paraná), Bruno Dallagiovanna; the director of the Molecular Biology Institute of Paraná (IBMP), Pedro Barbosa; and the researcher at the AIDS and Molecular Immunology Laboratory of the Oswaldo Cruz Institute (IOC/Fiocruz), Gonzalo Bello. On the Uruguayan side, several authorities were present, including UdelaR’s President, Rodrigo Arim; the Vice-President of Teaching, Juan Cristina; Internal Affairs Coordinating Commission Chairman, Rodney Colina; and the director of the Pasteur Institute of Montevideo, Carlos Batthyány.

“The agreement is another step in the search for closer ties between the institutions, which already have partnerships in a particular way. The purpose of the Memorandum of Understanding is to institutionalize the cooperation, expanding scientific development, the exchange of students and researchers, and joint funding”, said José Paulo.

At the meeting, work groups defined, for the beginning of the activities, major thematic axes for the development of research projects: virology, Leishmania, technology transfer and technical-scientific training.

Experts stressed the importance of prioritizing research on emerging and reemerging viruses such as dengue, zika, chikungunya and yellow fever, as well as studies on gastroenteric and respiratory viruses. Proposals were also designated for the elaboration of joint health surveillance strategies, the creation of integrated reference laboratories and the development of diagnosis kits and clinical studies.

In addition to the creation of a macro-project, covering different areas of knowledge, joint notices between three institutions are planned. The next meeting should take place in the first semester of 2020.

Back to the topBack